PODD250117C220000
- 48.10
- 0.000.00%
Insulet Newsroom
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
Weekly Buzz: Finally a Good Week for 2025
Wall Street Today: Trump's on Deck After Market Nearly Hits Year High
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
Wall Street Today: Thursday Earnings Looked a Lot More Mixed, and Philly is Booming
Live Stock News: Sideways Trading Market After Big TSMC, UNH Earnings, Philly Economy is Booming
Citi Maintains Insulet(PODD.US) With Buy Rating
Wall Street Today: JPM and Banking Leads Market Higher
Live Stock: Banks Break the Bank on Earnings, Inflation Looks Tame for Dec
Bernstein Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $315
Analysts Conflicted on These Healthcare Names: Elevance Health (ELV), Agilent (A) and Insulet (PODD)
Wall Street Today: Market Barely Climbs, Wholesale Inflation Grows Less Than Feared
Insulet To Present At J.P. Morgan 43rd Annual Healthcare Conference; Webcast At 6:45 PM ET
Live Stock News: Tuesday Market Climbs and TikTok Sale Might be Incoming
Insulet Begins Commercial Sales of Omnipod 5 Insulin Delivery System in 5 More Countries
Wall Street Today: Market Turns Around, Let's See if it Lasts
Express News | Insulet Launches Omnipod 5 In Five More Countries In Italy, Denmark, Finland, Norway And Sweden
Live Stock News: Monday Market Falling, 'Too Big to Fail' Earnings to Start Q1 Report Season
We Think Insulet (NASDAQ:PODD) Can Stay On Top Of Its Debt
Weekly Buzz: CES Came and Brought the Pain? That's Unexpected